Anticancer Effects of ACT001 via NF-κB Suppression in Murine Triple-Negative Breast Cancer Cell Line 4T1

PURPOSE: ACT001 is a novel sesquiterpene lactone derivative with anticancer effects, including the reversal of tamoxifen resistance in estrogen receptor-positive breast cancer cells. However, few studies have investigated the anticancer effects of ACT001 in triple-negative breast cancer (TNBC), a hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanyang, Wang, Li, Liu, Jiewei, Xie, Xiaoxiao, Hu, Haoyue, Luo, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326172/
https://www.ncbi.nlm.nih.gov/pubmed/32617021
http://dx.doi.org/10.2147/CMAR.S244748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326172/
https://www.ncbi.nlm.nih.gov/pubmed/32617021
http://dx.doi.org/10.2147/CMAR.S244748

Ejemplares similares